xFOREST Therapeutics

📍 Kyoto, Japan🗓 Founded 2020👥 14 employees💰 Last funded 2020
Pharmaceutical Manufacturing🌐 xforestx.com
Website LinkedIn
xFOREST Therapeutics is a Kyoto-based young biotech company. At xFOREST, we develop a proprietary screening pipeline to find RNA-targeting small molecules with the goal to develop them into new drugs that treat previously untreatable diseases. Our pipeline includes both a highly automated laboratory system of liquid- and labware-handling devices and an automated analysis pipeline capable of statistically analyzing millions of potential RNA-small molecule interactions flagging promising hit-pairs. Our vision is to become a next-generation discovery platform that utilizes synergies between wet and dry lab, based on big data and AI.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2020
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Japan
1
Frequently asked questions
Who invested in xFOREST Therapeutics?
xFOREST Therapeutics has 1 investors on record on gritt.io, including 1 early-stage backers.
When did xFOREST Therapeutics last raise funding?
The most recent investment in xFOREST Therapeutics recorded on gritt.io was in 2020.
When was xFOREST Therapeutics founded?
xFOREST Therapeutics was founded in 2020.
What industry is xFOREST Therapeutics in?
xFOREST Therapeutics operates in Pharmaceutical Manufacturing. Find similar Pharmaceutical Manufacturing investors on gritt.io.
Where is xFOREST Therapeutics based?
xFOREST Therapeutics is headquartered in Kyoto, Japan.